We are live on ! Find out more

281 hedge funds and large institutions have $2.17B invested in RXO in 2023 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 85 increasing their positions, 87 reducing their positions, and 62 closing their positions.

New
Increased
Maintained
Reduced
Closed

26% more capital invested

Capital invested by funds: $1.72B → $2.17B (+$445M)

8.57% more ownership

Funds ownership: 86%94.56% (+8.6%)

2% less repeat investments, than reductions

Existing positions increased: 85 | Existing positions reduced: 87

4% less funds holding

Funds holding: 294281 (-13)

16% less first-time investments, than exits

New positions opened: 52 | Existing positions closed: 62

57% less call options, than puts

Call options by funds: $5.76M | Put options by funds: $13.4M

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

Holders
281
Holders Change
-13
Holders Change %
-4.42%
% of All Funds
4.47%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
52
Increased
85
Reduced
87
Closed
62
Calls
$5.76M
Puts
$13.4M
Net Calls
-$7.69M
Net Calls Change
-$7.5M

RXO Hedge Fund Activity: Q1 2023 in Review

281 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in RXO (RXO) for Q1 2023, worth a combined $2.17B — up 26% from $1.72B a quarter earlier.

Sellers outnumbered buyers: 62 funds closed out of RXO and 52 opened new positions — a net loss of 10 holders — while 87 trimmed existing stakes and 85 added.

The largest buyer was BlackRock, adding an estimated $92.2M. The largest seller was Massachusetts Financial Services, cutting an estimated $32.1M.

  • 281 institutional investors held RXO (RXO) as of Q1 2023, down from 294 in Q4 2022.
  • Funds reported $2.17B of RXO stock for Q1 2023, up 26% quarter-over-quarter.
  • 52 funds opened new RXO positions in Q1 2023 and 62 closed out, a net change of -10 holders.
  • The largest RXO buyer in Q1 2023 was BlackRock, an estimated $92.2M added.
  • The largest RXO seller in Q1 2023 was Massachusetts Financial Services, an estimated $32.1M sold.

Based on aggregated 13F filings for Q1 2023.